These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6660172)

  • 21. The prophylactic treatment of bronchial asthma in children with ketotifen: a double-blind comparison with placebo.
    Spicak V
    J Int Med Res; 1983; 11(3):173-8. PubMed ID: 6347749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years.
    Rackham A; Brown CA; Chandra RK; Ho P; Hoogerwerf PE; Kennedy RJ; Knight A; Langer H; Milne J; Moote DW
    J Allergy Clin Immunol; 1989 Sep; 84(3):286-96. PubMed ID: 2674262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double blind placebo controlled study on the use of ketotifen in childhood asthma.
    Mulhern B; O'Connor N; Hillery M; Ward OC
    Ir Med J; 1982 Jan; 75(1):25-8. PubMed ID: 7085236
    [No Abstract]   [Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with ketotifen in respiratory tract diseases].
    Wenz W; Mohorn M; Jäger L
    Allerg Immunol (Leipz); 1986; 32(3):215-22. PubMed ID: 2947446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of Zaditen syrup in the treatment of children with bronchial asthma].
    Sciślicki A; Rudnik J; Gaweł J; Lukasik A; Werys R; Matoga S; Brański H
    Probl Med Wieku Rozwoj; 1983; 12():131-43. PubMed ID: 6371788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of the prophylactic effect of ketotifen and sodium cromoglycate in children with pollen-induced asthma.
    Graff-Lonnevig V; Kusoffsky E
    Schweiz Med Wochenschr; 1980 Feb; 110(6):195-6. PubMed ID: 6769158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of ketotifen (HC20-511) in bronchial asthma.
    Paterson JW; Yellin RH; Tarala RA
    Eur J Clin Pharmacol; 1983; 25(2):187-93. PubMed ID: 6414821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone plasma levels in children treated for 6 months with ketotifen.
    Dolecek R; Janstová V; Halatová A
    Pharmatherapeutica; 1984; 3(9):588-91. PubMed ID: 6728863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of ketotifen in young children with asthma.
    Volovitz B; Varsano I; Cumella JC; Jaber L
    J Allergy Clin Immunol; 1988 Mar; 81(3):526-30. PubMed ID: 3279095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic treatment of childhood asthma.
    Castello D
    Int J Clin Pharmacol Res; 1986; 6(5):373-8. PubMed ID: 3096899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of long term treatment of asthmatic children with hyposensitization, ACTH, DSCG and Ketotifen.
    Osváth P; Endre L
    Allergol Immunopathol (Madr); 1984; 12(6):471-7. PubMed ID: 6099051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The orally administered anti-allergic agent, ketotifen; efficacy in atopic and non-atopic bronchial asthma.
    Carrasco E; Galleguillos F; Bernath Z
    Allergol Immunopathol (Madr); 1981; 9(4):335-42. PubMed ID: 7030036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of ketotifen and aminophylline on the central and peripheral airways.
    Dorow P; Schiess W
    Arzneimittelforschung; 1983; 33(2):265-8. PubMed ID: 6682668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled trial of ketotifen in exercise-induced asthma.
    Tanser AR; Elmes J
    Br J Dis Chest; 1980 Oct; 74(4):398-402. PubMed ID: 6783059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the circadian rhythm in 3, 5 cAMP in bronchial asthma after administration of ketotifen.
    Fernández M; Neffen H; Sanz ML; Oehling A
    Allergol Immunopathol (Madr); 1981; 9(5):405-10. PubMed ID: 6295126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.